期刊文献+

Clostridioides difficile infection in liver cirrhosis patients: A population-based study in United States 被引量:1

下载PDF
导出
摘要 BACKGROUND Clostridioides(formerly Clostridium)difficile infection(CDI)is an increasingly frequent cause of morbidity and mortality in hospitalized patients.Multiple risk factors are documented in the literature that includes,but are not limited to,antibiotics use,advanced age,and gastric acid suppression.Several epidemiological studies have reported an increased incidence of CDI in advanced liver disease patients.Some have also demonstrated a higher prevalence of nosocomial infections in cirrhotic patients.AIM To use a large nationwide database,we sought to determine CDI’s risk among liver cirrhosis patients in the United States.METHODS We queried a commercial database(Explorys Inc^(TM),Cleveland,OH,United States),and obtained an aggregate of electronic health record data from 26 major integrated United States healthcare systems comprising 360 hospitals in the United States from 2018 to 2021.Diagnoses were organized into the Systematized Nomenclature of Medicine Clinical Terms(SNOMED–CT)hierarchy.Statistical analysis for the multivariable model was performed using Statistical Package for Social Sciences(SPSS version 25,IBM CorpTM).For all analyses,a two-sided P value of<0.05 was considered statistically significant.RESULTS There were a total of 19387760 patients in the database who were above 20 years of age between the years 2018-2021.Of those,133400 were diagnosed with liver cirrhosis.The prevalence of CDI amongst the liver cirrhosis population was 134.93 per 100.000 vs 19.06 per 100.000 in non-cirrhotic patients(P<0.0001).The multivariate analysis model uncovered that cirrhotic patients were more likely to develop CDI(OR:1.857;95%CI:1.665-2.113,P<0.0001)compared to those without any prior history of liver cirrhosis.CONCLUSION In this large database study,we uncovered that cirrhotic patients have a significantly higher CDI prevalence than those without cirrhosis.Liver cirrhosis may be an independent risk factor for CDI.Further prospective studies are needed to clarify this possible risk association that may lead to the implementation of screening methods in this high-risk population.
出处 《World Journal of Hepatology》 2021年第8期926-938,共13页 世界肝病学杂志(英文版)(电子版)
  • 相关文献

参考文献4

二级参考文献37

  • 1Chalermrat Bunchorntavakul,Disaya Chavalitdhamrong.Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis[J].World Journal of Hepatology,2012,4(5):158-168. 被引量:29
  • 2[1]Bartlett JG,Moon N,Chang TW,Taylor N,Onderdonk AB.Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.Gastroenterology 1978; 75:778-782
  • 3[2]Bartlett JG.Clostridium difficile:clinical considerations.Rev Infect Dis 1990; 12 Suppl 2:S243-S251
  • 4[3]Kelly CP,Pothoulakis C,LaMont JT.Clostridium difficile colitis.N Engl J Med 1994; 330:257-262
  • 5[4]Aslam S,Hamill RJ,Musher DM.Treatment of Clostridium difficile-associated disease:old therapies and new strategies.Lancet Infect Dis 2005; 5:549-557
  • 6[5]Gorbach SL.Antibiotics and Clostridium difficile.N Engl J Med 1999; 341:1690-1691
  • 7[6]McFarland LV.Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients.Am J Infect Control 1995; 23:295-305
  • 8[7]Kyne L,Warny M,Qamar A,Kelly CP.Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.N Engl J Med 2000; 342:390-397
  • 9[8]Kelly CP,Pothoulakis C,LaMont JT.Clostridium difficile colitis.N Engl J Med 1994; 330:257-262
  • 10[9]Mylonakis E,Ryan ET,Calderwood SB.Clostridium difficile-Associated diarrhea:A review.Arch Intern Med 2001; 161:525-533

共引文献51

同被引文献9

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部